Logo image of CORZ

CORE SCIENTIFIC INC (CORZ) Stock Fundamental Analysis

NASDAQ:CORZ - Nasdaq - US21874A1060 - Common Stock - Currency: USD

10.83  +0.05 (+0.46%)

After market: 10.9193 +0.09 (+0.82%)

Fundamental Rating

3

CORZ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. CORZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CORZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CORZ had negative earnings in the past year.
In the past year CORZ had a positive cash flow from operations.
In the past 5 years CORZ reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CORZ reported negative operating cash flow in multiple years.
CORZ Yearly Net Income VS EBIT VS OCF VS FCFCORZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

CORZ has a Return On Assets of -70.20%. This is amonst the worse of the industry: CORZ underperforms 85.51% of its industry peers.
Industry RankSector Rank
ROA -70.2%
ROE N/A
ROIC N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CORZ Yearly ROA, ROE, ROICCORZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

CORZ's Gross Margin of 23.71% is on the low side compared to the rest of the industry. CORZ is outperformed by 79.51% of its industry peers.
CORZ's Gross Margin has improved in the last couple of years.
CORZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
CORZ Yearly Profit, Operating, Gross MarginsCORZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

CORZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CORZ has less shares outstanding
CORZ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CORZ has an improved debt to assets ratio.
CORZ Yearly Shares OutstandingCORZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CORZ Yearly Total Debt VS Total AssetsCORZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CORZ has an Altman-Z score of -1.60. This is a bad value and indicates that CORZ is not financially healthy and even has some risk of bankruptcy.
CORZ's Altman-Z score of -1.60 is on the low side compared to the rest of the industry. CORZ is outperformed by 76.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.6
ROIC/WACCN/A
WACC10.21%
CORZ Yearly LT Debt VS Equity VS FCFCORZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

CORZ has a Current Ratio of 6.72. This indicates that CORZ is financially healthy and has no problem in meeting its short term obligations.
CORZ's Current ratio of 6.72 is amongst the best of the industry. CORZ outperforms 91.52% of its industry peers.
A Quick Ratio of 6.72 indicates that CORZ has no problem at all paying its short term obligations.
CORZ's Quick ratio of 6.72 is amongst the best of the industry. CORZ outperforms 91.52% of its industry peers.
Industry RankSector Rank
Current Ratio 6.72
Quick Ratio 6.72
CORZ Yearly Current Assets VS Current LiabilitesCORZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CORZ have decreased strongly by -2858.82% in the last year.
Looking at the last year, CORZ shows a small growth in Revenue. The Revenue has grown by 1.65% in the last year.
The Revenue has been growing by 53.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2858.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%681.25%
Revenue 1Y (TTM)1.65%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-60.43%

3.2 Future

Based on estimates for the next years, CORZ will show a very strong growth in Earnings Per Share. The EPS will grow by 27.43% on average per year.
CORZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.90% yearly.
EPS Next Y96.15%
EPS Next 2Y43.19%
EPS Next 3Y27.43%
EPS Next 5YN/A
Revenue Next Year-17.74%
Revenue Next 2Y29.81%
Revenue Next 3Y32.63%
Revenue Next 5Y6.9%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CORZ Yearly Revenue VS EstimatesCORZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
CORZ Yearly EPS VS EstimatesCORZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CORZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 35.16, the valuation of CORZ can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as CORZ.
CORZ is valuated expensively when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 35.16
CORZ Price Earnings VS Forward Price EarningsCORZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CORZ indicates a somewhat cheap valuation: CORZ is cheaper than 74.20% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.53
CORZ Per share dataCORZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

CORZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CORZ's earnings are expected to grow with 27.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.19%
EPS Next 3Y27.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CORZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE SCIENTIFIC INC

NASDAQ:CORZ (5/22/2025, 4:45:50 PM)

After market: 10.9193 +0.09 (+0.82%)

10.83

+0.05 (+0.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners90.02%
Inst Owner Change-4.17%
Ins Owners4.45%
Ins Owner Change2.57%
Market Cap3.19B
Analysts84.55
Price Target18.87 (74.24%)
Short Float %17.41%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-878.49%
Min EPS beat(2)-1154.44%
Max EPS beat(2)-602.54%
EPS beat(4)1
Avg EPS beat(4)-3913.43%
Min EPS beat(4)-13917.4%
Max EPS beat(4)20.66%
EPS beat(8)3
Avg EPS beat(8)-2043.44%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.79%
Min Revenue beat(2)-8.73%
Max Revenue beat(2)-6.86%
Revenue beat(4)2
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-8.73%
Max Revenue beat(4)13.65%
Revenue beat(8)3
Avg Revenue beat(8)-5.11%
Revenue beat(12)5
Avg Revenue beat(12)-4.66%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.13%
PT rev (3m)-9.9%
EPS NQ rev (1m)-12.77%
EPS NQ rev (3m)-103.34%
EPS NY rev (1m)-11.9%
EPS NY rev (3m)-230.27%
Revenue NQ rev (1m)-2.69%
Revenue NQ rev (3m)-16.3%
Revenue NY rev (1m)-13.99%
Revenue NY rev (3m)-35.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 35.16
P/S 6.25
P/FCF N/A
P/OCF 74.45
P/B N/A
P/tB N/A
EV/EBITDA 32.53
EPS(TTM)-5.03
EYN/A
EPS(NY)0.31
Fwd EY2.84%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.15
OCFY1.34%
SpS1.73
BVpS-2.78
TBVpS-2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -70.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.71%
FCFM N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.17
Cap/Depr 84.09%
Cap/Sales 18.64%
Interest Coverage N/A
Cash Conversion 40.63%
Profit Quality N/A
Current Ratio 6.72
Quick Ratio 6.72
Altman-Z -1.6
F-Score4
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)122.96%
Cap/Depr(5y)360.66%
Cap/Sales(3y)38.66%
Cap/Sales(5y)43.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2858.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%681.25%
EPS Next Y96.15%
EPS Next 2Y43.19%
EPS Next 3Y27.43%
EPS Next 5YN/A
Revenue 1Y (TTM)1.65%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-60.43%
Revenue Next Year-17.74%
Revenue Next 2Y29.81%
Revenue Next 3Y32.63%
Revenue Next 5Y6.9%
EBIT growth 1Y-149.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year917.07%
EBIT Next 3Y216.42%
EBIT Next 5Y187.34%
FCF growth 1Y-208.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.12%
OCF growth 3YN/A
OCF growth 5YN/A